Repeated semaglutide treatment attenuates cocaine-vs-food choice in male and female rats

Read full text
Authors: Nicholas Heslep, Samuel A. Marsh, Matthew L. Banks
Cited by: 3
References: 13

Abstract

The present study determined the effectiveness of the glucagon-like peptide 1 agonist semaglutide to attenuate cocaine-vs-food choice in male and female rats. Repeated 5-day semaglutide treatment decreased cocaine choice and significantly reduced body weight. These preclinical results support the clinical evaluation of semaglutide as a candidate cocaine use disorder medication.

Fields of Study & Subjects

Diabetes Treatment and Management Regulation of Appetite and Obesity Pancreatic function and diabetes

Publication details

Journal / source
Neuropsychopharmacology
Publisher
Springer Science and Business Media LLC
Volume
51
Issue
7
Pages
1144–1146
Publication date
15 April 2026
Language
EN